Literature DB >> 6200307

Evoked potentials in patients with Huntington's disease and their offspring. I. Somatosensory evoked potentials.

J Noth, L Engel, H H Friedemann, H W Lange.   

Abstract

Spinal and cortical somatosensory evoked potentials (SEPs) were recorded in a large sample of patients with Huntington's disease (n = 37) and subjects at risk (first order offspring, n = 43). The SEPs were elicited by stimulation of the median and tibial nerves and recorded at Erb's point, the cervical level (C2) and at the corresponding scalp areas. The most striking finding in patients with Huntington's disease was a drastic diminution of the amplitude of the early cortical components, especially N20/P25 for the median nerve and N33/P40 for the tibial nerve. The latencies (Erb's point, C2, cortical) were only slightly prolonged in comparison to the normal values. Forty-three per cent of the persons at risk exhibited pathological results with a clear reduction in amplitude of the early cortical responses or with a pathological side difference between the amplitudes. Fifty-three per cent of the persons at risk exhibited a normal result. Two persons at risk (= 6%) could not be classified unambiguously. Some patients with benign and symptomatic chorea were investigated. These showed normal results with one exception. The diagnostic and predictive value of the investigation of SEPs in Huntington's disease is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6200307     DOI: 10.1016/0168-5597(84)90029-7

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  9 in total

1.  Standard neurodiagnostic tests in Sydenham's chorea.

Authors:  R F Gledhill; P D Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

Review 2.  Some comments on the clinical use of evoked potentials.

Authors:  S L Notermans; E J Colon
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

3.  EMG responses in leg muscles to postural perturbations in Huntington's disease.

Authors:  J Huttunen; V Hömberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

4.  Comparative EEG mapping studies in Huntington's disease patients and controls.

Authors:  Annamaria Painold; Peter Anderer; Anna K Holl; Martin Letmaier; Gerda M Saletu-Zyhlarz; Bernd Saletu; Raphael M Bonelli
Journal:  J Neural Transm (Vienna)       Date:  2010-10-08       Impact factor: 3.575

5.  New mutation to Huntington's disease.

Authors:  G Wolff; G Deuschl; T F Wienker; K Hummel; K Bender; C H Lücking; M Schumacher; J Hammer; G Oepen
Journal:  J Med Genet       Date:  1989-01       Impact factor: 6.318

6.  Different mechanisms underlie the long-latency stretch reflex response of active human muscle at different joints.

Authors:  A F Thilmann; M Schwarz; R Töpper; S J Fellows; J Noth
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

7.  Electrophysiological analysis of motor control in patients with vascular hemichorea.

Authors:  G Abbruzzese; G Brusa; D Dall'Agata; M Morena; L Spadavecchia; E Favale
Journal:  Ital J Neurol Sci       Date:  1987-08

8.  Cortical and striatal neurone number in Huntington's disease.

Authors:  H Heinsen; M Strik; M Bauer; K Luther; G Ulmar; D Gangnus; G Jungkunz; W Eisenmenger; M Götz
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease.

Authors:  T Kuwert; H W Lange; H Boecker; H Titz; H Herzog; A Aulich; B C Wang; U Nayak; L E Feinendegen
Journal:  J Neurol       Date:  1993-11       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.